Resolution of new daily persistent headache by a tumor necrosis factor alpha antagonist, Venlafaxine

por Tariq, Zeshan, Board, Nathan, Eftimiades, Alex, Ibrahim, Ronnie
Publicado 2019

B cell overexpression of FCRL5 and PD-1 is associated with low antibody titers in HCV infection

por Ogega, Clinton O., Skinner, Nicole E., Flyak, Andrew I., Clark, Kaitlyn E., Board, Nathan L., Bjorkman, Pamela J., Crowe, James E., Cox, Andrea L., Ray, Stuart C., Bailey, Justin R.
Publicado 2022

A cell-free antigen processing system informs HIV-1 epitope selection and vaccine design

por Sengupta, Srona, Zhang, Josephine, Reed, Madison C., Yu, Jeanna, Kim, Aeryon, Boronina, Tatiana N., Board, Nathan L., Wrabl, James O., Shenderov, Kevin, Welsh, Robin A., Yang, Weiming, Timmons, Andrew E., Hoh, Rebecca, Cole, Robert N., Deeks, Steven G., Siliciano, Janet D., Siliciano, Robert F., Sadegh-Nasseri, Scheherazade
Publicado 2023

TCR-mimic bispecific antibodies to target the HIV-1 reservoir

por Sengupta, Srona, Board, Nathan L., Wu, Fengting, Moskovljevic, Milica, Douglass, Jacqueline, Zhang, Josephine, Reinhold, Bruce R., Duke-Cohan, Jonathan, Yu, Jeanna, Reed, Madison C., Tabdili, Yasmine, Azurmendi, Aitana, Fray, Emily J., Zhang, Hao, Hsiue, Emily Han-Chung, Jenike, Katharine, Ho, Ya-Chi, Gabelli, Sandra B., Kinzler, Kenneth W., Vogelstein, Bert, Zhou, Shibin, Siliciano, Janet D., Sadegh-Nasseri, Scheherazade, Reinherz, Ellis L., Siliciano, Robert F.
Publicado 2022